Can a tailored blood thinner dose save lives after Weight-Loss surgery?
NCT ID NCT05569681
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two different doses of the blood thinner bemiparin to see which works better at preventing dangerous blood clots in people with severe obesity after surgery. About 2,400 participants will be enrolled. The goal is to find the safest and most effective dose for this high-risk group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MORBID OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hawler Medical university
RECRUITINGErbil, Kurdistan Region, 44001, Iraq
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple drug cut bleeding risk in weight-loss surgery?
- Blood test clues could flag Weight-Surgery risks
- Can a higher dose of misoprostol help women with severe obesity avoid C-Section?
- Fasting test may unlock personalized obesity treatment
- Painkiller form may matter after gastric bypass
- Poop pills from skinny donors: a new weapon against obesity?